Cargando…
Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder of largely unknown pathogenesis. Recent studies suggest that enhanced oxidative stress and neuroinflammation contribute to the progression of the disease. Mounting evidence implicates the receptor for advanced glycation end-product...
Autores principales: | Juranek, Judyta K., Daffu, Gurdip K., Wojtkiewicz, Joanna, Lacomis, David, Kofler, Julia, Schmidt, Ann Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686801/ https://www.ncbi.nlm.nih.gov/pubmed/26733811 http://dx.doi.org/10.3389/fncel.2015.00485 |
Ejemplares similares
-
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
por: Juranek, Judyta K., et al.
Publicado: (2016) -
Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis
por: Nowicka, Natalia, et al.
Publicado: (2019) -
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018) -
COMPLEX TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS PATIENT
por: Białkowska, Joanna, et al.
Publicado: (2019) -
Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis
por: Wilson, Meghan E., et al.
Publicado: (2010)